Ignite Creation Date:
2024-05-05 @ 11:25 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00031915
Status:
COMPLETED
Last Update Posted:
2013-06-19
First Post:
2002-03-08
Brief Title:
Imatinib Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma or Bone Sarcoma
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Childhood Malignant Fibrous Histiocytoma of Bone |
| Sarcoma |
Keywords:
| Name | View |
|---|---|
| fibrosarcomatous osteosarcoma | View |
| metastatic osteosarcoma | View |
| recurrent childhood rhabdomyosarcoma | View |
| recurrent osteosarcoma | View |
| embryonal childhood rhabdomyosarcoma | View |
| alveolar childhood rhabdomyosarcoma | View |
| pleomorphic childhood rhabdomyosarcoma | View |
| metastatic childhood soft tissue sarcoma | View |
| recurrent childhood soft tissue sarcoma | View |
| childhood fibrosarcoma | View |
| childhood synovial sarcoma | View |
| childhood liposarcoma | View |
| childhood alveolar soft-part sarcoma | View |
| childhood neurofibrosarcoma | View |
| childhood angiosarcoma | View |
| childhood malignant fibrous histiocytoma of bone | View |
| previously treated childhood rhabdomyosarcoma | View |
| metastatic Ewing sarcomaperipheral primitive neuroectodermal tumor | View |
| recurrent Ewing sarcomaperipheral primitive neuroectodermal tumor | View |